EGFR and glioblastoma: By contrast, EGFR was observed, with variable intensities, in 85% of GBM samples (45/53) (Figure 3B,C), and p-EGFR was observed, with diffuse and often patchy staining, in 77% of GBM samples (41/53) (Figure 3E,F).